NHS should end Palantir contract to protect medical confidentiality and state autonomy

Source: https://www.theguardian.com/profile/editorial. "The Guardian view on NHS records: patients are not raw material for big tech | Editorial | The Guardian." June 4, 2026. www.theguardian.com

The Gist

The NHS should cancel its contract with Palantir because the company can access private patient data without proper safeguards, which breaks trust and helps foreign shareholders profit from British public data. The government should use UK-owned alternatives instead to protect both patient privacy and national independence.

Conclusion

The UK government should activate the break clause in the NHS's £330m Palantir contract and move to in-house or UK-owned providers

Premises

  1. Palantir engineers can gain unlimited access to identifiable NHS patient data, violating promises that such access would be limited to NHS staff with legitimate need
  2. Patient trust will be undermined if sensitive medical information can be disclosed to US tech corporations, leading patients to withhold crucial health information
  3. The current arrangement benefits US shareholders rather than the British public, as Britain supplies raw NHS data while Silicon Valley monetizes it
  4. Palantir is not just a software firm but has worked on controversial military and immigration programs, with a co-founder who disparages national health services
  5. Public bodies have become dangerously dependent on powerful foreign technology companies that the state cannot effectively challenge or replace
  6. Critical public infrastructure resting on foreign-owned platforms undermines state autonomy and blurs accountability

Assumptions

View this argument on LogicFirst.ai